Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertensionheart failure and percutenous coronary interventions (PCI).

Videos | Heart Valve Technology | February 18, 2020
Andrew Weintraub, M.D., FACC, associate director, of the Interventional Cardiology and Vascular Center, medical...
Videos | Antiplatelet and Anticoagulation Therapies | February 18, 2020
Carey Kimmelstiel, M.D., FACP, FACC, director, interventional cardiology, director, cardiac catheterization lab, Tufts...
Radial access in the U.S. is now approaching 50 percent. Tranradial access also shows benefit for mortality and decreases in acute kidney injury (AKI).
Feature | Radial Access | February 14, 2020 | Dave Fornell, Editor
Transradial access for percutaneous coronary intervention (PCI) in the United States has grown rapidly over the past 20...
A CSI Diamondabck 360 atheretectomy system in use during a cath lab procedure at Henry Ford Hospital in Detroit. Photo by Dave Fornell

A CSI Diamondabck 360 atheretectomy system in use during a cath lab procedure at Henry Ford Hospital in Detroit. Photo by Dave Fornell

News | Atherectomy Devices | February 13, 2020
February 13, 2020 — The U.S. Food and Drug Administration (FDA) has issued its final guidance on "Peripheral Vascular...
The DEFINE GPS (Distal Evaluation of Functional performance with Intravascular sensors to assess the Narrowing Effect: Guided Physiologic Stenting) study will be the first time that the use of iFR in conjunction with the Philips Image-Guided Co-registration System (SyncVision) is evaluated for PCI guidance and the optimization of treatment outcomes.

The DEFINE GPS study will be the first time that the use of iFR in conjunction with an angiography image-guided co-registration system for PCI guidance and the optimization.

News | Cath Lab Navigation Aids | February 12, 2020
February 12. 2020 — Philips announced a new randomized controlled trial to assess patient outcomes after receiving a...
he University of Wisconsin (UW) Health’s University Hospital in Madison, Wis., recently became the first facility in the United States to install the Artis icono biplane angiography imaging system from Siemens Healthineers.
News | Angiography | February 12, 2020
February 12, 2020 — The University of Wisconsin (UW) Health’s University Hospital in Madison, Wis., recently became the...
The Boston Scientific Eluvia self-expanding, drug-eluting, peripheral stent.

The Boston Scientific Eluvia self-expanding, drug-eluting, peripheral stent.

Feature | Stents | February 11, 2020 | Saloni Walimbe
Cardiovascular diseases (CVDs) are among the leading causes of death across the globe. For patients suffering from high...
DSA image obtained approximately 24 hours after 1 mg/h IA tPA infusion, 500 U/h heparin via peripheral IV, and daily oral aspirin (81 mg) shows improved perfusion of digital arteries, albeit with suboptimal vascular blush of distal second and third phalanges. Photo courtesy of ARRS

DSA image obtained approximately 24 hours after 1 mg/h IA tPA infusion, 500 U/h heparin via peripheral IV, and daily oral aspirin (81 mg) shows improved perfusion of digital arteries, albeit with suboptimal vascular blush of distal second and third phalanges. Photo courtesy of ARRS

News | Interventional Radiology | February 11, 2020
February 11, 2020 — An ahead-of-print article in the April issue of the American Journal of Roentgenology (AJR)...
Videos | Heart Failure | February 10, 2020
Interview with James Udelson, M.D., chief of the division of cardiology at Tufts Medical Center, Boston. The hospital...
The Aria CV Pulmonary Hypertension System (Aria CV PH System) received FDA Breakthrough Device status.
News | Hypertension | February 07, 2020
February 7, 2020 — The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the Aria...
Videos | Hemodynamic Support Devices | February 07, 2020
Interview with Navin Kapur, M.D., FAHA, FACC, FSCAI, executive director, The CardioVascular Center for Research and...
New SIR position statement and quality documents highlight interventional radiology effective use of nonsurgical ablation to treat kidney cancer in selected patients
News | Interventional Radiology | February 04, 2020
February 4, 2020 — For some patients, kidney cancer can be effectively treated without surgery, according to the...
The U.S. Food and Drug Administration (FDA) has approved a the CATALYST trial designed to assess Abbott's Amplatzer Amulet left atrial appendage (LAA) occluder for people with atrial fibrillation (AF or AFib). 
News | Left Atrial Appendage (LAA) Occluders | February 03, 2020
February 3, 2020 — The U.S. Food and Drug Administration (FDA) has approved a the CATALYST trial designed to assess...
The Abbott Tendyne transcatheter mitral valve replacement (TMVR) system, left, became the first TMVR device to gain commercial regulatory clearance in the world. It gains European CE mark in January. Another top story in January was the first use of the Robocath R-One robotic cath lab catheter guidance system in Germany.  Watch a VIDEO of the system in use in one of those cases. 

The Abbott Tendyne transcatheter mitral valve replacement (TMVR) system, left, became the first TMVR device to gain commercial regulatory clearance in the world. It gains European CE mark in January. Another top story in January was the first use of the Robocath R-One robotic cath lab catheter guidance system in Germany.  Watch a VIDEO of the system in use in one of those cases. 

News | February 03, 2020 | Dave Fornell, Editor
February 3, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC)...